Catalyst Wire Dossier Catalyst Wire Dossier

LipaCreon

· Mylan Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LipaCreon, covering 2022-06-10 to 2022-06-13. Get the full timeline:

Most recent: Clinical Trial Update: Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency

See pricing